®
X
GALA
CONFERENCE
®
WHY BLOOM BURTON & CO?
SERVICES
TRANSACTIONS
TEAM
EVENTS
News & Insights
CAREERS
CONTACT
•
M
E
N
U
•
news
April 29, 2016
Bloom Burton's analyst Dave Martin discusses Canadian healthcare risks and opportunities on BNN
Bloom Burton’s analyst Dave Martin discusses Canadian healthcare risks and opportunities on BNN
Click on the image to view the full video.
RELATED NEWS
See All News
Richards Group Inc. Announces Acquisition of the CPG Assets of PharmaSystems Inc.
Three Finalists Announced for the 2026 Bloom Burton Award
Crescita Announces Definitive Agreement to Be Acquired by ClinActiv Holdings in an All-Cash Transaction at a Significant Premium
Australian-Listed @PYC Therapeutics (ASX:PYC) Raises A$600 Million from Leading Healthcare Specialist Investors, Institutional Investors and Existing Investors
Eupraxia Pharmaceuticals Announces Closing of US$63.2 Million Public Offering Including Full Exercise of Underwriter Option
Registration is now open for the 2026 Bloom Burton & Co. Healthcare Investor Conference!
Satellos Closes US$57.2 Million Public Offering in Canada and the United States, Including Exercise of Underwriters’ Option to Purchase Additional Shares
Bloom Burton & Co. Announces the 2026 Bloom Burton Award
Conavi Medical Corp. Announces Closing of $12M Public Offering
LSL Pharma Group Announces Closing of $12M Private Placement
